golimumab
Showing 1 - 25 of 42
Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab, Placebo)
Not yet recruiting
- Psoriatic Arthritis
- Guselkumab
- +2 more
-
Philadelphia, PennsylvaniaHospital at the University of Pennsylvania
Dec 20, 2022
Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab)
Not yet recruiting
- Psoriatic Arthritis
- Guselkumab
- Golimumab
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 18, 2022
Axial Spondyloarthritis Trial in Bonheiden, Ghent, Hasselt (Golimumab)
Recruiting
- Axial Spondyloarthritis
- Golimumab
-
Bonheiden, Antwerpen, Belgium
- +2 more
Nov 30, 2022
Diabetes, Type 1 Trial in San Diego (Golimumab)
Available
- Diabetes Mellitus, Type 1
- Golimumab
-
San Diego, CaliforniaRady Children's Hospital
Jul 28, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)
Active, not recruiting
- Arthritis, Juvenile
- Golimumab
- Methotrexate
-
San Diego, California
- +37 more
Jan 17, 2023
Golimumab in Juvenile Idiopathic Arthritis-associated Uveitis
Completed
- JIA Associated Uveitis
- Golimumab
- (no location specified)
Sep 1, 2021
Modulation of Gut Microbiota in Ulcerative Colitis
Completed
- Ulcerative Colitis
- Golimumab
-
Girona, Catalonia, SpainHospital Doctor Josep Trueta
Jun 28, 2021
Ulcerative Colitis Trial in London (Golimumab)
Completed
- Ulcerative Colitis
- Golimumab
-
London, United KingdomGuy's & St Thomas' NHS Foundation Trust
Jul 2, 2021
Pre-Symptomatic Type 1 Diabetes Trial in Finland, Sweden, United States (Golimumab, Placebo)
Completed
- Pre-Symptomatic Type 1 Diabetes
- Golimumab
- Placebo
-
Aurora, Colorado
- +7 more
Sep 9, 2021
ULCERATIVE COLITIS Trial in Belgium, France (GOLIMUMAB)
Active, not recruiting
- ULCERATIVE COLITIS
- GOLIMUMAB
-
Liege, Belgium
- +22 more
Jun 28, 2021
Diabetes, Type 1 Trial (Golimumab, Placebo)
Withdrawn
- Diabetes Mellitus, Type 1
- Golimumab
- Placebo
- (no location specified)
Nov 19, 2021
Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)
Recruiting
- Psoriatic Arthritis
- +2 more
- Prednisolone
- +14 more
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen
Nov 10, 2022
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Hepatosplenic T-Cell Lymphoma Trial in Norfolk (Infliximab, Golimumab)
Completed
- Hepatosplenic T-Cell Lymphoma
- Infliximab
- Golimumab
-
Norfolk, Virginia(unnamed)
Feb 12, 2021
Crohn's Disease Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)
Not yet recruiting
- Crohn's Disease
- Guselkumab
- +3 more
-
Birmingham, Alabama
- +167 more
Jul 14, 2022
Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis
Unknown status
- Arthritis, Rheumatoid
- Golimumab
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 3, 2019
(CHOIR)
Recruiting
- Chronic Nonbacterial Osteomyelitis
- Chronic Recurrent Multifocal Osteomyelitis
- Methotrexate
- +9 more
-
Seattle, WashingtonSeattle Children's Hospital
Jan 25, 2021
Colitis, Ulcerative Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)
Not yet recruiting
- Colitis, Ulcerative
- Guselkumab
- +3 more
-
Arcadia, California
- +236 more
Jul 14, 2022
Psoriatic Arthritis Trial in Leeds (Golimumab, Methotrexate)
Unknown status
- Psoriatic Arthritis
- Golimumab
- Methotrexate
-
Leeds, West Yorkshire, United KingdomThe Leeds Teaching Hospitals NHS Trust
Sep 27, 2019